Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
43.48
-0.21 (-0.48%)
Nov 21, 2024, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 222.97 | 286.33 | 28 | 31.34 | 142.09 | 11.97 | Upgrade
|
| Short-Term Investments | 61.48 | - | 123.72 | 125.2 | 89.73 | 104.69 | Upgrade
|
| Cash & Short-Term Investments | 284.45 | 286.33 | 151.72 | 156.54 | 231.82 | 116.66 | Upgrade
|
| Cash Growth | -7.05% | 88.72% | -3.08% | -32.47% | 98.71% | 124.51% | Upgrade
|
| Accounts Receivable | 68.53 | 67.97 | 23.99 | 3.27 | - | - | Upgrade
|
| Other Receivables | - | - | - | 0.3 | - | - | Upgrade
|
| Receivables | 68.53 | 67.97 | 23.99 | 3.57 | - | - | Upgrade
|
| Inventory | 21.59 | 22.31 | 5.57 | 1.51 | - | - | Upgrade
|
| Prepaid Expenses | 12.06 | 10.94 | 8.95 | 4.97 | 4.53 | 2.7 | Upgrade
|
| Total Current Assets | 386.63 | 387.54 | 190.23 | 166.59 | 236.35 | 119.36 | Upgrade
|
| Property, Plant & Equipment | 10.35 | 1.99 | 2.35 | 2.55 | 3.24 | 3.73 | Upgrade
|
| Long-Term Investments | 9.32 | - | - | 4.98 | - | 23.29 | Upgrade
|
| Other Intangible Assets | 255.79 | 252.93 | 58.95 | 18.74 | - | - | Upgrade
|
| Other Long-Term Assets | 5.81 | 4.17 | 101.38 | 101.79 | 1.27 | 0.32 | Upgrade
|
| Total Assets | 667.89 | 646.62 | 352.91 | 294.65 | 240.86 | 146.71 | Upgrade
|
| Accounts Payable | 9.55 | 7.42 | 8.69 | 9.17 | 3.15 | 3.35 | Upgrade
|
| Accrued Expenses | 64.11 | 54.89 | 34.73 | 24.42 | 13.41 | 9.33 | Upgrade
|
| Current Portion of Leases | 1.51 | 1.1 | 0.93 | 0.71 | 0.64 | 0.4 | Upgrade
|
| Other Current Liabilities | 40.59 | 23.65 | 20.37 | 8.3 | 1.26 | - | Upgrade
|
| Total Current Liabilities | 115.75 | 87.06 | 64.73 | 42.6 | 18.46 | 13.08 | Upgrade
|
| Long-Term Debt | 307.67 | 306.42 | - | - | - | - | Upgrade
|
| Long-Term Leases | 8.48 | 0.62 | 1.26 | 1.9 | 2.63 | 3.25 | Upgrade
|
| Other Long-Term Liabilities | 3.97 | 3.85 | 144.88 | 129.94 | 47.68 | 0.04 | Upgrade
|
| Total Liabilities | 435.87 | 397.95 | 210.87 | 174.44 | 68.77 | 16.36 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 851.49 | 803.26 | 535.07 | 377.4 | 345.18 | 200.12 | Upgrade
|
| Retained Earnings | -620.39 | -556.24 | -392.82 | -257.16 | -173.17 | -69.9 | Upgrade
|
| Comprehensive Income & Other | 0.92 | 1.64 | -0.22 | -0.04 | 0.08 | 0.13 | Upgrade
|
| Total Common Equity | 232.02 | 248.67 | 142.04 | 120.21 | 172.1 | 130.35 | Upgrade
|
| Shareholders' Equity | 232.02 | 248.67 | 142.04 | 120.21 | 172.1 | 130.35 | Upgrade
|
| Total Liabilities & Equity | 667.89 | 646.62 | 352.91 | 294.65 | 240.86 | 146.71 | Upgrade
|
| Total Debt | 317.65 | 308.14 | 2.19 | 2.61 | 3.26 | 3.65 | Upgrade
|
| Net Cash (Debt) | -33.21 | -21.82 | 149.53 | 153.93 | 228.56 | 113.01 | Upgrade
|
| Net Cash Growth | - | - | -2.86% | -32.65% | 102.24% | 117.49% | Upgrade
|
| Net Cash Per Share | -0.70 | -0.53 | 4.40 | 5.08 | 9.05 | 9.84 | Upgrade
|
| Filing Date Shares Outstanding | 48 | 47 | 37.95 | 31.73 | 30.42 | 24.97 | Upgrade
|
| Total Common Shares Outstanding | 47.97 | 46.72 | 36.96 | 30.58 | 29.78 | 22.6 | Upgrade
|
| Working Capital | 270.88 | 300.48 | 125.5 | 124 | 217.89 | 106.29 | Upgrade
|
| Book Value Per Share | 4.84 | 5.32 | 3.84 | 3.93 | 5.78 | 5.77 | Upgrade
|
| Tangible Book Value | -23.77 | -4.26 | 83.08 | 101.47 | 172.1 | 130.35 | Upgrade
|
| Tangible Book Value Per Share | -0.50 | -0.09 | 2.25 | 3.32 | 5.78 | 5.77 | Upgrade
|
| Machinery | - | 0.9 | 0.6 | 0.2 | 0.3 | 0.2 | Upgrade
|
| Leasehold Improvements | - | 1.31 | 1.31 | 1.48 | 1.29 | 1.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.